Marker Therapeutics News

Marker Therapeutics | ARS: Annual Report to Security Holders

Apr 27 04:34

Marker Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:11

Marker Therapeutics | 8-K: Current report

Apr 8 19:12

Marker Therapeutics | 10-K: Annual report

Mar 27 01:28

Marker Therapeutics | 8-K: Current report

Mar 27 01:28

Marker Therapeutics | 8-K: Current report

Mar 1 21:06

Marker Therapeutics | 8-K: Current report

Feb 26 21:00

Marker Therapeutics | 8-K: Current report

Jan 8 13:00

Marker Therapeutics | 8-K: Current report

Dec 11, 2023 20:35

Marker Therapeutics | 8-K: Current report

Nov 21, 2023 05:37

Marker Therapeutics | 8-K: Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Nov 10, 2023 06:03

Marker Therapeutics: Q3 2023 Earnings Report

Nov 10, 2023 05:31

Marker Therapeutics | 8-K: Current report

Sep 11, 2023 19:10

Marker Therapeutics | 8-K: Marker Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 15, 2023 04:37

Marker Therapeutics | 10-Q: Q2 2023 Earnings Report

Aug 15, 2023 04:03

Marker Therapeutics | 8-K: Current report

Aug 7, 2023 19:22

Marker Therapeutics | 8-K: Current report

Jul 10, 2023 19:09

Marker Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lurier Eliot M

Jul 6, 2023 04:22

Marker Therapeutics | 8-K: Current report

Jul 4, 2023 04:05

Marker Therapeutics | 8-K: Current report

Jul 1, 2023 04:05